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Abstract 
Single nucleotide polymorphisms (SNPs) constitute the most common types of genetic 
variations in the human genome. A number of SNPs have been linked to the development of 
life threatening diseases including cancer, cardiovascular diseases and neurodegenerative 
diseases. The ability for ultrasensitive and accurate detection of low abundant disease-related 
SNPs in bodily fluids (e.g. blood, serum, etc.) holds a significant value in the development of 
non-invasive future biodiagnostic tools. Over the past two decades, nanomaterials have been 
utilized in a myriad of biosensing applications due to their ability of detecting extremely low 
quantities of biologically important biomarkers with high sensitivity and accuracy. Of 
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particular interest is the application of such technologies in the detection of SNPs. The use of 
various nanomaterials, coupled with different powerful signal amplification strategies, has 
paved the way for a new generation of ultrasensitive SNP biodiagnostic assays. Over the past 
few years, several ultrasensitive SNP biosensors capable of detecting specific targets down to 
the ultra-low regimes (ca. aM and below) and therefore holding great promises for early 
clinical diagnosis of diseases have been developed. This mini review will highlight some of 
the most recent, significant advances in nanomaterial-based ultrasensitive SNP sensing 
technologies capable of detecting specific targets on the attomolar (10
-18 
M) regime or below. 
In particular, the design of novel, powerful signal ampliﬁcation strategies that hold the key to 
the ultrasensitivity is highlighted. 
 
1. Introduction 
The completion of the human genome project in 2003 [1] has led to several important 
discoveries relating to structure of the human genome: it is characterized by variations in 
DNA nucleotide sequences of one or more bases in genes of the same population [2-3]. These 
variations in DNA impart certain phenotypic traits that distinguish an organism from another. 
If such variations occur in greater than one percent of the human population, they are 
collectively referred to as polymorphisms. On the other hand, variations occurring in less 
than one percent of the population are often termed as “mutations” which are associated with 
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a detrimental phenotype such as those linked with various cases of cancer [3]. The most 
common sequence variation occurring in the human genome is the stable substitution of a 
single nucleotide, also known as single nucleotide polymorphisms (SNPs). The human 
genome has been estimated to contain more than 10 million SNPs which are distributed 
across the human genome at an estimated frequency of at least one nucleotide every 1000 
base pairs but with apparent regional differences [4-5]. While most SNPs do not alter the 
metabolic function and expression levels of a gene, some do result in differences in 
predisposition to certain heritable diseases [6-8], response to drugs (pharmacogenetics) [9-
10], and perception of pain [11]. Several studies have shown that SNPs are closely associated 
with many types of cancer and presupposes the risk of cancer progression [12-15]. For 
instance, it was observed that single point mutations in the KRAS gene at codons 12, 13, and 
61 are associated with the development of certain pancreatic [14] and lung cancers [15]. 
Moreover, numerous detrimental and inheritable diseases such as diabetes [7], vascular 
diseases [16], some forms of neurodegenerative and mental illness [17-18] have also been 
linked to SNPs. On the other hand, microRNAs (miRNAs) which are 17 – 24 base short RNA 
molecules playing important roles in numerous cellular processes such as differentiation, 
cellular growth, and apoptosis. Point mutations in miRNAs have been associated with several 
forms of cancers, affecting the cancer risk and treatment efficacy in some non-small cell lung 
cancer patients [19-20]. These are just a few examples highlighting the association of SNPs in 
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relation to human diseases and treatment responses, demonstrating the tremendous value of 
SNPs in biomedical research. Indeed, SNPs are considered as an important class of 
biomarkers that could allow scientists and medical practitioners to better understand certain 
diseases, develop novel non-invasive diagnostics tool and ultimately allow for a more 
personalized approach to disease treatment and therapies. 
The most established techniques for point mutation detections in DNA have largely 
relied on the amplification power of the polymerase chain reaction (PCR) coupled with 
quantitative fluorescence detection and/or DNA sequencing techniques such as pyro-/next 
generation sequencing of the amplified product. Although highly sensitive and widely used, 
such methods can sometimes introduce errors during the PCR exponential amplification 
process which is sensitive to contaminations and hence may affect diagnostic accuracy [21-
22]. PCR is also often regarded as labor-intensive and time-consuming, making it unsuitable 
for rapid, point-of-care diagnostics. Moreover, it also requires an expensive thermal cycler 
and thereby the cost per analysis might be high for developing countries. These limitations 
have largely hampered the wide use of PCR for rapid, on-site diagnostics. In the case of point 
mutation detections involving miRNAs, the real-time quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) is often the method of choice due to its high 
sensitivity. However, several drawbacks do exist for the qRT-PCR, including complex 
processes such as reverse transcription, multiple primer design, and precise temperature 
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control [23]. Unsurprisingly, many of the recent developments have focused on developing 
PCR-free alternatives in SNP biosensing. The reliable detection of low abundance specific 
SNPs without PCR pre-amplification represents an extremely challenging albeit exciting 
research area of the bioanalytical science. 
Over the past few years, enormous efforts have been directed towards the development 
of novel, ultrasensitive PCR-free SNP assays and a number of techniques have been 
developed [22, 24-27]. The detection and quantification of known SNPs are primarily based 
on the specificity of target hybridization [28-29] and enzyme discriminations, such as specific 
enzymatic cleavage [30], and single base primer extension [31-32]. Of particular interest in 
the early stages of PCR-free SNP biosensing development has been based on using water-
soluble, cationic conjugated polymers (CCPs) as fluorescence transducers. For example, the 
Leclerc group [33-34] has pioneered and developed DNA detection based on the electrostatic 
attraction between a cationic polythiophene and DNA. The colour and fluorescence changes 
of the polymer in the presence of single-stranded and double-stranded DNAs were used as the 
basis for biosensing. They have reported the first detection of SNPs directly from clinical 
samples without the need of DNA pre-amplification with an impressive detection limit of 3 
zeptomolar. The Bazan and Hageer groups have also detected specific DNA sequences via 
CCP sensitised Förster resonance energy transfer (FRET) to dye-labelled probes [35-36]. The 
electrostatic attraction between the cationic CCPs and the anionic DNAs leads to short 
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distance donor (CCP)-acceptor (DNA dye-label), hence strong FRET [37]. A substantive 
review of such work has already been provided by Swager et al. [38], and hence this will not 
be main topic here.    
Recently, the use of various nanomaterials has provided the capability of ultrasensitivity 
and high specificity in SNP detection. Nanomaterials have been well-studied primarily 
because of their unique, size dependent physical and chemical properties. In terms of 
biosensing applications, such useful properties include extremely large surface area, tunable 
surface chemical composition that allow easy and controlled immobilization of stable 
bioreceptors for efficient transduction of target binding into strong readout signals. These 
properties are advantageous for achieving ultrasensitivities, allowing easy integration into 
miniaturized devices ushering an era of next generation cost-effective SNP diagnostics.  
Nanomaterials such as metallic nanoparticles (NPs) 
[39-44,55]
, quantum dots (QDs) 
[45- 48]
, 
magnetic nanoparticles (MNPs) 
[49-54]
, and carbon based nanomaterials 
[56]
 have been 
combined with biomolecules such as enzymes, oligonucleotides and DNAzymes to develop 
sensors for detection and quantification of cancer-specific SNPs. Such nanomaterial-based 
SNP assays have been coupled with a number of different readout strategies, including 
colorimetry, fluorimetry, surface enhanced Raman spectroscopy (SERS), electrochemical and 
electrochemiluminescence etc. For example, Boudreau and colleagues recently reported the 
use of FRET-based CCP transducers by combining them with highly fluorescent core - shell 
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nanoparticles. The Ag nanoparticle core was used to amplify the optical signal generated 
upon target recognition. This plasmonic enhancement resulted to the direct detection of 
unamplified target nucleic acid at femtomolar concentration regime 
[57-59]
.  
Table 1 summarizes some of the recently developed ultrasensitive SNP assays using 
different nanomaterials coupled with different probe and/or signal amplification strategies. 
The sensitivities and specificities of these assays are already comparable to, or even surpass 
those of many PCR based techniques, demonstrating the high suitability of nanomaterials for 
ultrasensitive SNP detection. Despite significant developments, it is important to consider 
some other burgeoning challenges in clinical diagnosis, particularly in the quantification of 
extremely low abundant SNPs in an overwhelming background of wild-type genes in clinical 
settings. Moreover, the ability of simultaneous detection of multiple targets is also important 
for high diagnostic accuracy because “no tumor marker identified to date is sufficiently 
sensitive or specific to be used on its own to screen for cancer” [60-61]. The practical 
importance of these relies on the fact that most cancer cases are only diagnosed in the late 
stage and when the chances of patient survival are already slim. As a result, early diagnosis is 
of paramount importance for improving the survival and prognosis of cancer patients. All 
these necessitate the development of ultrasensitive assays with multiplexing capability that 
can detect the extremely low concentrations of cancer-specific SNPs in clinically media. 
In general, three different approaches are widely employed to improve the assay 
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detection limits: target, probe, and signal amplification. Among these, target amplification is 
mainly achieved via enzyme-mediated replication of target nucleic acid sequences, leading to 
ca. 10
8
-10
9
 fold amplification of target concentration to make it high enough to be readily 
detected by traditional approaches such as gel electrophoresis [22]. An excellent example 
here is the well established polymerase chain reaction (PCR). More recently, isothermal 
target amplification strategies have also been developed [24-27, 62] and displayed 
sensitivities comparable to that of the PCR. In contrast, probe amplification does not change 
the copy number of the target, but instead the probe sequence which is complementary to the 
target is amplified and detected by conventional hybridization method. Signal amplification 
strategies are approaches that amplify the analytical signal generated by each labeled or 
unlabelled probe so as to increase the assay sensitivity. Various signal amplification strategies 
have been used to increase the sensitivity of the probe-based assays. 
In this mini-review, we will highlight some of the most recent advance in the field of 
nanomaterial-based SNP detection, with a particular focus on those techniques capable of 
detecting and quantifying extremely low target concentrations down to the attomolar regimes 
or below. Given the high specificity, the hybridization-based method remains one of the most 
popular methods for nanomaterial based SNP assays. In general, the ultra-sensitivity of these 
assays have been achieved through one of the following five different strategies, [i] 
nanoparticle–target assisted PCR amplification, [ii] nanoparticle-target assisted probe 
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amplification, [iii] target recycling coupled with probe amplification, [iv] tandem 
amplification coupled with signal catalytic cascades, and [v] nanomaterial enhanced signal 
amplification. Each of these classes will be discussed in this review with a focus on the assay 
sensitivity and comment on their applicability to real biological matrices. Moreover, a critical 
categorization of such existing approaches on the basis of different amplification strategies is 
proposed. 
 
(i) Nanoparticle – Target Assisted PCR Amplification Strategy 
An essential first step in this approach is to pre-amplify the extremely low abundant 
SNP target into sufficiently high number of copies so that it can be readily detected by 
conventional methods. Given its extremely powerful exponential amplification power, it is 
unsurprising that PCR-based SNP biosensing assays have been reported to have high 
sensitivities.[63] In particular, the incorporation of plasmonic nanomaterials such as Au and 
Ag nanoparticles has been recently combined with PCR pre-amplification of the target DNA, 
leading to unprecedented sensitivities. For example, Kotov and colleagues have reported an 
unexpected chirality of bridged metallic nanoparticle dimers and have exploited this in 
ultrasensitive biosensing. They have prepared different sized Au and Ag NPs and 
functionalized them with specific antibodies so that they can sandwich bind the specific target 
protein (e.g. prostate specific antigen PSA, a cancer marker) and assemble into hetero-
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nanoparticle dimers. These biomolecule bridged NP heterodimers are chiral, leading to an 
observable change in circular dichroism (CD) spectra over 350-600 nm region. The authors 
found that this assay was extremely sensitive, capable to detecting PSA down to the sub-aM 
level with an extremely impressive detection limit (DL) of 1.5 × 10
-20 
M and a linear dynamic 
range of ~ 3 orders of magnitude. Such a highly impressive sensitivity has been attributed to 
plamonic enhancement of intrinsic chirality of biomolecules, strong optical coupling of 
photons with twisted NP heterodimers, and bisignate nature of the CD spectra [64-65]. 
 This assay has been recently modified to suit the detection of ultralow concentrations of 
DNA [66] by applying a PCR amplification of the dsDNA with primers linked to Au NPs (25 
nm Au NP-linked forward primer and 10 nm Au NP-linked reverse primer) in the presence of 
Taq polymerase and dNTPs (see Fig. 1). The DNA-bridged Au NP heterodimers displayed 
circular dichromism (CD) bands at 260 and 525 nm, attributed to the chiral secondary 
structures of duplex DNA and the chiral NP dimers, respectively. These dimers displayed 
unexpected chirality due to the ellipsoidal shape of the NPs and a scissor-like configuration 
with two long NP axes forming a dihedral angle of 10
o
. Coating of the Au NP dimers with Ag 
or Au are found to affect their chiro-plasmonic activity: as the thickness of the Ag shell 
increased, the intensity of the CD bands also increased and shifted from 525 to 418 nm. In the 
case of Au coating, increasing the Au shell thickness resulted in a color change of the 
dispersion from pink to purple and the CD bands exhibited a 61 nm red shift. More 
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importantly, Au coating of DNA-bridged Au NP dimers gave fairly narrow spectra with high 
optical anisotropy. Optimization of assay parameters such as specific design of primers and 
number of PCR cycles has yielded ultrasensitive DNA assay with a linear dynamic range 
spanning 7 orders of magnitude (from 160 zM to 1.6 pM) and an extremely low DL of 17 
zM. Currently, this method reported the highest sensitivity for DNA detection using 
nanomaterials based sensing platforms, and hence appears to have good potential for genetic 
based early diagnostic applications. Despite such great sensitivity, the applicability of this 
assay towards the detection and discrimination of specific SNP’s in complex media such as 
the wild-type DNA background has yet to be demonstrated. Moreover, given the fact that this 
assay requires PCR pre-amplification, it is less well-suited to applications that require rapid 
results such as the point-of-care diagnostics.  
 
(ii) Nanoparticle - Target Assisted Probe Amplification Strategy 
Rolling circle amplification (RCA) [67-69] and ligase chain reaction (LCR) [70-72] are two 
of the most extensively used probe amplification strategies in SNP detections. Recently, 
nanomaterials have been combined with these probe amplification assays, leading to further 
improvements in detection limits. These assays typically use a complementary 
oligonucleotide capture probe chemically linked to an Au nanoparticle, quantum dot, or 
magnetic nanoparticle to directly interact with their specific analytes, thereby amplifying 
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molecular recognition events such as DNA hybridization. In addition, magnetic nanoparticles 
have been further used for target capture, enrichment and purification which can further 
enhance the assay sensitivity. 
 Unlike PCR which requires thermal cycles, RCA is an isothermal probe amplification 
strategy using a single-stranded DNA as a padlock probe (Fig. 2A). The 5’- (phosphate 
modified) and 3’- terminal fragments of the padlock probe are specifically designed to be 
complementary to the target DNA. Hybridisation of the target to the padlock probe then 
brings its 5’- and 3’- terminus close to each other, forming a nicked circle which can be 
covalently ligated together by a DNA ligase if the padlock and target sequences are fully-
matched, forming a circularized padlock probe. The circularised padlock probe is then 
amplified by a φ29 polymerase in the presence of dNTP’s, producing a greatly elongated 
single-stranded DNA containing numerous copies of repeat tandem sequence units 
complementary to the circular padlock probe. In contrast, the presence of a single-base 
mismatch at the nicked target/padlock duplex probe can prevent the specific ligation and 
formation of the circular padlock probe, and therefore no RCA amplification (Fig. 2B). The 
stringent requirement of full sequence complementary between the padlock and target to form 
the ligated circular padlock probe allows the RCA strategy to have excellent specificity for 
SNP detection [42, 77]. 
Similar to PCR, the ligase chain reaction (LCR) also requires multiple thermal cycles to 
Page 12 of 51Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
$Q
DO\
VW
$F
FH
SWH
G0
DQ
XV
FUL
SW
Pu
bl
ish
ed
 o
n 
12
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f L
ee
ds
 o
n 
12
/0
3/
20
15
 2
1:
47
:3
3.
 
View Article Online
DOI: 10.1039/C4AN02304H
  
13 
 
achieve specific ligation of two short DNA probes catalysed by a DNA ligase into a single 
strand templated by a full-match DNA target [24-27]. In a typical SNP assay, LCR uses two 
pairs of probes each containing two short complementary oligonucleotides, but the overall 
sequence is complementary to the target DNA sequence (Fig. 3). After thermal denaturation 
followed by annealing, a pair of the probes are hybridized to one of the denatured target DNA 
strand. They are subsequently ligated by a DNA ligase if the probes and target sequences are 
fully complementary at the nick site. On the other hand, the presence of single-base mismatch 
at the nick site can prevent specific ligation, allowing for the LCR to have high SNP 
selectivity. After the first ligation round, each ligated product can then function as a new 
template to ligate further probes in the following thermal cycles. Repeating the thermal cycles 
thus leads to an exponential increase of the ligated probes. Ligation reactions have better 
single-base mismatch discriminatory ability than primer extension methods, making LCR 
more specific for SNP detection than PCR based methods [24]. 
A particularly attractive SNP assay has been the colorimetric sensing using Au NPs 
because of their extremely strong surface plasmon resonance (SPR) absorption at ~520 nm 
(ε > 10
9
 M
-1
.cm
-1
 for a 20 nm Au NP, 4-5 orders of magnitudes stronger than typical organic 
dyes), making it strongly colored even at low nM concentrations. Moreover, its SPR band is 
also sensitive to aggregation, isolated Au NPs appear red but aggregated ones are blue or 
purple. The resulting color change is distinct and clearly visible by the naked eye [27]. Here 
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specific DNA targets that can induce the aggregation of Au NPs have been used to detect 
SNPs, taking the full advantage of the very sharp melting transition for the sandwich duplex 
formed between the target DNA and a pair of probe DNA (with sequence complementary to 
each half of the DNA target) modified Au NPs. The sharp melting transition means a single-
base mismatch between the target and probes can be distinguished due to their slightly 
different thermal stability. This leads to distinct color changes at elevated temperatures that 
can be exploited for SNP detection [73-74]. Combined with various amplification strategies, 
such assays have achieved pretty low detection limits, down to the femtomolar region.  
More recently, LCR has been combined with Au NP for ultrasensitive colorimetric SNP 
detection by the Gao group [40]. The assay involves the real time ligation of oligonucleotide 
coated Au NPs templated by the complementary SNP target (Fig. 4A). In each LCR cycle, 
there is an increasing amount of Au NPs being ligated that are subsequently used to template 
the ligation of further Au NPs, leading to an exponential increase in the amount of 
covalently linked Au NPs. Since the SPR band of Au NPs is sensitive to NP assembly, this 
resulted in a color change that can be directly monitored by UV-vis (Fig. 4B). This assay has 
an impressive linear dynamic range of 6 orders of magnitude and is capable of detecting 
specific DNA targets down to 20 aM. This assay also has high selectivity: it can specifically 
detect the wild-type (WT) KRAS gene in the presence of large excesses of genomic DNAs 
even at 1:100000 (KRAS:genomic DNA) base pair ratios when readings were taken at 90 
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o
C. At this temperature, all non-chemically ligated DNA–Au NP conjugates were dislodged, 
leaving only the covalently ligated Au NPs in the solution. Thus, the incorporation of 
ligation allowed for easy elimination of interferences from coexisting DNA and a reduced 
background. This assay has been further detected the WT-KRAS in the presence of KRAS 
single point mutants, yielding an impressive SNP selectivity factor of 2000. This assay can 
be used as an efficient approach for detecting specific mutant DNAs by simply redesigning 
the sequences of capture probes and signal probes, and thus has great potential for 
ultrasensitive detection of various disease-related SNPs. Despite such great promises, the 
relatively long assay time and requirement of multiple thermal cycles may limit its use in 
rapid, point-of-care applications. 
 Although the LCR strategy appears to be a highly attractive alternative to PCR 
amplification, an apparent weakness has been its low amplification efficiency when being 
combined with nanomaterials. This is due to the restricted accessibility of the ligases to the 
ligation site in oligonucleotide modified Au NPs. In an attempt to overcome the limitations of 
conventional LCR, a process called enzyme-free click chemical ligation reaction (CCLR) that 
involves Au NP and magnetic bead was developed by Kato and colleagues [75] (Fig. 5A). 
Unlike the earlier cross-linked Au NP systems, this assay does not require the use of ligases 
to carry out LCR and does not require the formation of large assemblies. The CCLR method 
uses an azide-containing DNA modified Au NP and a dibenzocyclooctyne-containing biotin-
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DNA probe. Sandwich hybridization of the target DNA (RNA) with the azide-DNA modified 
Au NP and biotin-DNA lead to enzyme-free ligation via the copper-free click chemistry, 
producing biotin–ligated Au NPs. Repeating the thermal cycles lead to the biotin-ligated Au 
NPs being exponentially amplified, which are then captured by using streptavidin–modified 
magnetic beads. After magnetic separation, the strong absorption of the Au NP can be used to 
detect and quantify the target DNA (RNA). Using this assay strategy, a DNA sequence 
associated with the hepatitis A virus Vall 7 polyprotein gene (HAV) has been detected at a 
concentration as low as 50 zM with a linear dynamic range of 3 orders of magnitude (Fig. 5 
B), which is highly impressive. However, it should be noted that the absolute signal 
difference throughout the whole dynamic range was relatively small, being only ~30% (e.g. 
increased from ~1.0 to 1.3), which can significantly limit its diagnosis accuracy. This method 
can also discriminate specific single point mutations, with the G-, T-, and C- Mutant signals 
being 17, 0, and 0% of that of the full-match control respectively. This shows that this essay 
has an excellent SNP discrimination, although a more useful demonstration of the SNP 
specificity would be the ability to detect low specific target SNPs in a background of wide-
type genes under clinical relevant media [75]. 
 
(iii) Target recycling coupled with probe and/or signal amplification. 
Target recycling is another useful strategy to amplify low copy number SNPs. In this 
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strategy, the target DNA is cycled in a number of hybridization events, each time producing 
one or several copies of the complementary probe strand, depending on the approaches used. 
However, the linear amplification nature of target recycling process has largely limited its 
detection limit to the fM regime only [53,76].  
More recently, target recycling has been combined with several other probe 
amplification strategies to further improve detection limits. A significantly higher sensitivity 
has been achieved by Ju and colleagues [46] who have designed a template enhanced 
hybridization process or TEHP coupled with rolling cycle amplification. This target recycling 
hybridization assay uses a biotinylated molecular beacon [MB] bound to a streptavidin coated 
plate as the template. Hybridization of the target DNA and an assistant DNA to the loop 
region of the MB forms a “Y” shaped junction (Fig. 6A). This configuration provided a 
specific nucleotide sequence that can be nicked by a suitable endonuclease. Once released, 
the target DNA and assistant DNA initiate another round of hybridization and strand scission 
cycle. The numerous MB fragments left in the plate then served as primers for the RCA 
process to produce thousands of repeat oligonucleotide sequences. These repeated sequences 
then are hybridized to an oligonucleotide functionalized CdTe QD and separated. The QDs 
are then dissolved by an acid, releasing greatly amplified Cd
2+
 ions that are detected by 
square wave voltammetry. The combination of TEHP and RCA coupled with the use of QD 
based signal tags has offered an enormous amplification of the DNA target, allowing for 
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greatly increased assay sensitivity. An impressive sensitivity of 11 aM has been attained 
together with a wide dynamic range of 6 orders of magnitude (Fig. 6 B-C). This assay was 
also able to discriminate the perfect complementary DNA target against various mismatch 
targets with a discrimination ratio of 3.8, 5.7 and 6.6 fold for the single-base, three-base 
mismatch and non-complementary oligonucleotides, respectively. Despite a high sensitivity, 
the mutant discrimination ratio here is relatively moderate compared to other specific SNP 
assays, which may limit its potential for applications in real clinical samples where the 
presence of large background genomic DNAs and/or wild-type genes may strongly interfere 
the specific SNP detection. 
 
(iv) Tandem amplification schemes and signal catalytic cascades 
In order to achieve detections in even lower concentration regimes, several researchers 
have reported the use of tandem amplification schemes [42, 77-78]. The combination of two 
amplification strategies has been deemed necessary to further improve the sensitivity and 
specificity of SNP detection. Moreover, this strategy can overcome the low amplification 
efficiency by a single amplification scheme. 
The colorimetric detection of SNPs using a combination of RCA and nicking 
endonuclease-assisted nanoparticle amplification strategy was developed by Xu and 
colleagues [42]. In this assay, ligation was performed when the target DNA was hybridized 
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with the padlock probe, leading to a circularized template. Subsequent RCA reaction in the 
presence of dNTPs led to the formation of a long single strand DNA. Nicking reactions at 
many of the repeated sites along the RCA elongated single-stranded DNA occurred 
simultaneously. Upon completion of the strand scission cycles, the addition of a specific 
oligonucleotide modified Au NP provided a simple, colorimetric detection of target DNA 
down to 1 pM.  
The sensitivity of ligation assays can be further improved when being coupled to another 
probe amplification scheme. For example, the combination of LCR and RCA in detecting 
SNPs has been recently demonstrated by Cheng and colleagues, [77] who has demonstrated 
the sensitive detection of 1 fM of unlabeled target DNA under the optimised assay conditions. 
Further improvements of assay sensitivity have been achieved by incorporation of 
DNAzymes (catalytic nucleic acids) based catalytic cascades signal amplification. In this 
regard, Zhang and colleagues [50] have designed a new RCA amplification approach where 
the presence of the target KRAS SNP triggers the ligation of the padlock probe. 
Subsequently, multiple other circular templates were interlocked to the padlock probe by 
means of complementary sequence forming an ABABAB-type DNA copolymer (Fig. 7A). 
The inter- locked circular primers containing the HRP-mimicking DNAzymes subsequently 
underwent another round of RCA, producing long, single-strand DNA products each 
containing thousands of copies of the repeated DNAzyme sequences acting catalytic units. 
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The incorporation of numerous such catalytic units thereby greatly enhanced the 
chemiluminescence signal in the presence of luminol and H2O2, leading to an impressive 
detection limit of 71 aM for the target SNP. This assay also provided excellent performance 
in quantitative analysis in human blood serum with a linear dynamic range of 2 orders of 
magnitude with good signal linearity from 0.1-10 fM (Fig. 7 B-C). The excellent sensitivity 
of this assay lies on the inherent capacity to generate great amplification as a consequence of 
the high turnover reaction of DNAzymes. This assay was also highly specific, and can detect 
1 fM specific mutant target in the presence of 10 pM wild-type gene background. It 
demonstrated a SNP detection capability of 1 in 10 000 (SNP versus wild-type target) level, 
which is among the best reported in literature. Hence, combining high sensitivity and 
specificity, this assay appears to have excellent potential for SNP based disease diagnostics 
by specific detection of the low abundant mutated target in clinical laboratory settings. This 
assay, however, is relatively complex and requires multiple amplification cycles, making it 
less well-suited for rapid, point-of-care applications. 
Recently, the Zhang group has developed an ultrasensitive miRNA assay based on 
primer generation - mediated rolling circle amplification [PG-RCA]. This assay was used to 
analyze the point mutation of mir-196a2 [T C] in the lung tissue samples of non small cell 
lung cancer patients [78]. In this assay, the presence of target mir-196a2T circularizes the 
padlock probe and the mir-196a2T further functioned as a primer to initiate the next round of 
Page 20 of 51Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
$Q
DO\
VW
$F
FH
SWH
G0
DQ
XV
FUL
SW
Pu
bl
ish
ed
 o
n 
12
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f L
ee
ds
 o
n 
12
/0
3/
20
15
 2
1:
47
:3
3.
 
View Article Online
DOI: 10.1039/C4AN02304H
  
21 
 
RCA reaction in the presence of Vent (exo-) polymerase. This resulted in a long single-
stranded RCA product containing numerous restriction sites for Nb.BsmI. The RCA product 
was then nicked by Nb.BsmI, generating a large number of new primers that was further used 
to initiate a new RCA reaction. The amplified DNA products were subsequently hybridized 
with a biotin/Cy5-labeled capture probes to form a double-stranded DNA. This DNA duplex 
contains a recognition site for the Nt.BstNBI nicking enzyme, and after the nicking reaction 
the capture probe was cleaved, separating Cy5 and biotin. This also resulted in the release of 
the amplified DNA product wherein it can repeatedly hybridize with new biotin/Cy5-labeled 
to initiate the next rounds of cleavage. In a similar strategy, mir-196a2C was detected using 
the designed mir-196a2C padlock probes. In the absence of the mir-96a2T, more Cy5/biotin 
capture probes are cleaved, leading to smaller amounts of the intact capture probes that can 
bind on the surface of the streptavidin-coated QD. Consequently, this reduces the FRET 
between the QD donor and Cy5 acceptors, resulting in decreased Cy5 counts being detected 
in the single-particle FRET detection measurement. On the other hand, the mir-196a2T-
specific linear padlock probe cannot be circularized in the absence of mir-196a2T. Under 
these conditions, RCA amplification and cleaving reactions will happen. Hence, the 
biotin/Cy5-labeled capture probe remains intact which can bind to the QD surface via 
specific streptavidin-biotin interactions, resulting in strong QD sensitised Cy5 FRET signal. 
With the integration of the PG-RCA reaction and nicking enzyme-driven recycling 
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amplification, this QD-based miRNA nanosensor exhibited an impressive detection limit of 
50.9 aM and a large dynamic range of 7 orders of magnitude from 0.1 fM to 1 nM for the 
specific microRNA taregt. Moreover, this assay can even distinguish variant frequencies 
down to as low as 0.001% in the mixtures of mir-196a2C and mir196a2T. Importantly, this 
QD-based miRNA nanosensor can be used to analyse the point mutation of mir-196a2 in the 
lung tissues of NSCLC patients, holding great potentials for further applications in 
biomedical research and clinical diagnosis presumably in the clinical laboratory settings. Its 
complex signal amplification and assay procedures together with a relatively complex single-
particle counting readout method may, however, limit its use in applications that require rapid 
results.    
(v) Nanomaterial assisted signal amplification 
In signal amplification, nanomaterials are often functionalised with biomolecules for 
target-specific recognitions and/or carrying high loads of signal moieties, catalysts, optical 
emitters, and electronic conductors. Biofunctionalised nanomaterials can amplify the signal 
transduction events due to their capability of direct interaction with their target, allowing for 
detection of biomolecules down to the single-molecule level [79]. Signal amplification can 
eliminate some special requirements of the target/probe amplification schemes such as the 
need of enzymes and thermal cycles (ca. PCR). As a result, this can simplify experimental 
protocols, lower the assay cost, and provide amenability to miniaturisation. Hence, the use of 
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biofunctionalized nanomaterials for signal amplification has been very attractive in the 
development of ultrasensitive DNA assays without the need of target and probe 
ampliﬁcations. The following section presents some ultrasensitive detection of SNPs 
achieved through use nanomaterials for signal amplification. 
 
5.1 Nanoparticle Bio-barcode Amplification 
An excellent example of the earlier developments here is the Bio-barcode assay 
developed by the Mirkin group [80]. It uses a short DNA-modified An NP tagged with 
hundreds of copies of the bio barcode DNAs (Bbc-Au NP) as signal probe, and another 
DNA-modified magnetic microparticle (Oligo-MMP) as capture probe (Fig. 8). The two 
DNAs are complementary to each half of the target DNA, so that they can sandwich bind to 
the target DNA, forming a Bbc-Au NP/DNA target/Oligo-MMP hybrid structure. After 
magnetic separation and washing to remove any unbound species, thermal denaturation of the 
hybrid releases the bio barcode DNAs, converting each capture DNA target into hundreds of 
copies of barcode DNAs. These are then detected by a sensitive scanometric assay coupled 
with silver amplification to achieve ultrasensitivity [81]. This assay provides an impressive 
label-free detection of target DNA down to 500 zM, comparable to many PCR based methods 
[80]. It can also discriminate the perfect match DNA from the SNP target. Although its 
relatively modest discrimination ratio, ~ 3:1, may limit its capability of detecting low 
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abundant SNP targets in wild-type gene background. 
 
5.2 Signal Amplification using labeled and enriched nanoparticle probes  
Metallic nanoparticles can be employed as scaffold for loading not only the capture but 
also signal molecules. These labelled nanoparticles present an important signal amplification 
strategy as they can directly enhance the readout signal for each target and probe recognition 
while retaining a high binding specificity. Over the past few years, silica particles have been 
used as another carrier platform due to their large surface areas, well-known surface 
chemistries and good biocompatibility.  
Wu and colleagues have reported a labeling-based signal amplification strategy for 
ultrasensitive detection of target DNA using QD assembled SiO2 microspheres [82]. This 
method is used as an indirect method for ultrasensitive detection of HIV DNA using hydride 
generation atomic fluorescence spectrophotometry [HG-AFS]. This assay involves the use of 
sandwich hybridization between the target DNA, biotin-capture probe and streptavidin tagged 
QD-SiO2 assembly, converting each captured DNA target into thousands of SiO2 tagged QDs. 
After acid dissolution of the QDs, the resulting Cd
2+
 ions were detected by HG-AFS, giving a 
highly impressive detection limit of 0.8 aM for the target DNA and a dynamic range of 3 
orders of magnitude (from 1 aM to 1 fM). The outstanding sensitivity suggests that the HG-
AFS method is suitable for the ultrasensitive biosensing.  
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An ultrasensitive chemiluminescent method using Au NP based signal amplification has 
recently been developed by Zhang and colleagues [83]. Using the Watson-Crick base pairing, 
a guanine monomer modified Au NP probe is coupled to the cytosine mutated DNA duplex in 
the presence of DNA polymerase I. Each guanine modified Au NP probe is also linked to 77 
CuS NPs which act as signal generator. After acid dissolution of the CuS NPs, the released 
Cu
2+
 ions are coordinated to cyanides to form [Cu(CN)4]
2- 
complexes. These are then reacted 
with luminol to give rise to chemiluminescence signal for target DNA quantification. A 
further improvement in the signal sensitivity is achieved by incorporating a pre-concentration 
of Cu
2+
 ions by anodic stripping voltammetry (ASV). These have enabled this assay to 
achieve a low detection limit of 19 aM for one base mutant DNA and a linear range of 80 aM 
to 10 fM. 
The labeling of the target DNA with a large number of signal generators coupled with 
sensitive electrochemiluminescence detection is very powerful towards ultrasensitivity for 
SNP detection as demonstrated by the Willner group [84]. In this assay, a mutant DNA with 
one base mismatch (CG mutation) is first hybridised to a complementary DNA modified 
magnetic NP. It is then treated with a DNA polymerase in the presence of biotin-dCTP and 
other dNTPs. This is then followed by multiple thermal cycles of dissociation, annealing and 
labeling, resulting in poly-labeling of the magnetic NPs with biotins. After magnetic 
separation and treatment with avidin-horseradish peroxidase (Avidin-HRP), the resulting 
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avidin-HRP functionalised magnetic NPs and napthoquinone NPs are deposited on an 
electrode guided by an external magnetic field. Applying an electric potential reduces 
napthoquinone to hydroquinone, which simultaneously reduces O2 to H2O2, triggering the 
HRP catalysed oxidation of luminol and yielding a chemiluminescence signal. Under 
optimized conditions, this assay has reported an impressive sensitivity of 8.3 aM for the 
M13φ DNA (50 copies in 10 µL sample) and 10 aM for a mutant DNA. 
 Despite showing impressive sensitivities, none of the above ultrasensitive assays have 
reported the simultaneous detection of multiple targets. Further developments on the 
multiplexing capability of an SNP assay are highly desirable for improving the diagnostic 
accuracy. Recently, Gambari and colleagues [85] have reported the direct detection of SNPs 
in non-amplified human genomic DNA carrying the mutated β
o
39-globin gene sequence by 
using surface plasmon resonance imaging (SPRI). This gene is involved in the hereditary 
blood disorder diseases known as β-thalassemia. The detection is achieved by using Au NP 
conjugated with multiple copies of DNA β
o
39, an 11-mer oligonucleotide. Prior to analysis, 
the surfaces of 6 microfluidic channels are modified with PNA-N and PNA-M probes whose 
nucleic acid sequences are complementary to the normal and mutant genes respectively (Fig. 
9). The samples are directly fluxed into these channels to allow the direct hybridisation 
between each of the samples (e.g. normal βN/βN; homozygous β
o
39/β
o
39 and heterozygous 
β
o
39/βN) on PNA functionalized surfaces. The SPRI responses between the samples and the 
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two diﬀerent PNA probes are used as controls. Subsequently, the conjugated Au NPs are 
fluxed into the microchannels and captured by specific hybridization between their surface 
DNA β
o
39 strands and exposed target DNA sequence not involved in binding to the PNA 
probes, allowing for greatly enhanced SPRI signal. This assay has achieved the sensitive 
detection of genomic DNAs down to 2.6 aM (5 pg µL
-1
) without PCR amplification. It can 
also discriminate between the normal, homozygous β
o
39/β
o
39, and heterozygous β
o
39/βN 
sequences, albeit with a relatively modest discrimination ratio. 
 
5.3 Signal Amplification using functionalized nanocontainers 
The use of nanomaterials with hollow structures for encapsulation of signaling elements 
is another attractive strategy for ultrasensitive biosensing. Lin and colleagues [48] have used 
a similar base-pairing mechanism to target DNA point mutations using a novel signal 
amplification strategy. It uses DNA polymerase I (Klenow fragment) to couple a guanine-
modified NP probe to the mutation site of a duplex DNA. The signal enhancement is 
achieved by incorporating Cd
2+
 ions inside an engineered protein with a hollow cage of 
interior cavity diameter of 8 nm. This NP probe is also modified with guanine nucleotide to 
specifically pair with cytosine point mutation in the DNA duplex. As a result, hybridization of 
the mutant DNA (cytosine point mutation) and the biotin-labeled DNA probe forms a stable 
duplex DNA structure which is then captured by avidin-modified magnetic NPs. The Cd
2+
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ions released from the nanoparticle cavity is then detected electrochemically by square wave 
voltammetry. This assay is sensitive, allowing for detection of 21.5 attomol mutant DNA and 
can detect SNPs down to frequencies as low as 0.01. 
Recently, Zhang and colleagues [86] has developed a new approach using QD-based 
SNP detection without the need for target or probe amplification. This assay uses a reporter 
probe modified-liposome (liposome-QD-reporter probe; L@QD complex) serving as a 
“nano- container” for encapsulation of hundreds of QDs. The presence of the target DNA (T-
DNA) and capture probe modified magnetic bead (CP-MB) lead to sandwich hybridization, 
forming a liposome-QD-reporter probe/T-DNA/CP-MB hybrid structure which is then 
separated magnetically. The subsequent disruption of liposome-QD complexes results in 
release of the encapsulated QDs, which are sensitively detected by single-particle counting 
(Fig.10). An advantage of this approach is that each pair of reporter/capture probes can be 
encoded with a different coloured QD, allowing for easy detection of multiple DNA targets 
simultaneously. 
As shown in Fig. 10, the presence of HIV-1 only produces fluorescence bursts from the 
green QDs but not the red QDs. In contrasts, the presence of HIV-2 only produces red QD 
fluorescence, but not green QD, and thus indicating high assay specificity. Multiplexing has 
been achieved by encapsulating red and green QDs into the respective reporter probe 1 and 
reporter probe 2 tagged liposomes, whereupon specific sandwich hybridization lead to the 
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formation of specific magnetic bead-liposome complexes. After magnetic separation, the use 
of two different coloured liposome-QD complexes has enabled the simultaneous detection 
of the HIV-1 and HIV-2 genes (Fig. 10 B-C). The great target amplification (each captured 
DNA targeted is converted into several hundreds of QDs) coupled with sensitive single-
particle counting method has enabled this assay to be ultrasensitive, with detection limits 
down to 1 and 2.5 aM for HIV-1 and for HIV-2, respectively. With the judicious design of 
capture and signal probes, this assay may provide an ultrasensitive approach for 
simultaneous detection of multiple DNA targets. However, this assay is unlikely to be able 
to provide high enough SNP discrimination ratio useful for detection of specific low 
abundant SNPs in wild-type gene background because of the small stability difference of the 
sandwich DNAs for the wild-type and SNP DNAs formed with the reporter/capture probes. 
Its single-particle counting readout strategy may also limit its application in resources poor 
environment. 
5.4 Signal Amplifications using enzyme guided crystal growth 
Stevens and colleagues have recently developed a novel plasmonic nanosensor that 
works on a principle of inverse sensitivity signal-generation mechanism, [87-88] where an 
amplified signal is observed when less target molecules are present. The inverse sensitivity 
procedure is achieved using glucose oxidase (GOx) which catalyses the generation of 
hydrogen peroxide to tailor the plasmonic response of the gold nanosensors. Depending on 
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the concentration, GOx can control the in-situ rate of nucleation of nascent Ag nanocrystals 
or Ag coating on Au nanostars, resulting in variations of the localized surface plasmon 
resonance (LSPR). At low GOx concentration, a low supply of H2O2 favours the deposition 
of a homogeneous silver coating on the Au nanostars, leading to blueshift of the LSPR band. 
Whereas a high GOx concentration favours the nucleation of silver nanocrystals instead of 
depositing on Au nanostars, leading to less LSPR shifts (Fig. 11). This principle is used to 
develop a plasmonic ELISA using a GOx conjugated antibody in a typical sandwich immune-
binding format. The concentration of GOx is directly related to the target concentration. 
Prostate speciﬁc antigen (PSA) and HIV-1 capsid antigen p24 are used as model protein 
targets in whole serum conditions. This assay has demonstrated an extremely impressive 
sensitivity of 40 zM [87] and 1 aM [88] for PSA and HIV-1 capsid antigen, respectively. 
Moreover, the assay results can be directly visualised by the naked eye, and therefore offers a 
simple, highly attractive alternative to the costly nucleic acid-based HIV infection diagnosis 
test. In principle, it can be adapted for the detection of any analyte with a suitable antibody, 
making it a versatile tool for ultrasensitive diagnostics. Despite of great simplicity and 
ultrasensitivity, the plasmonic ELISA however, has a rather small dynamic range of one order 
of magnitude, making it difficult to quantify the exact target concentration. 
 
Conclusion and Outlook 
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Significant advances have been made over the past few years in the development of 
PCR-free assays suitable for specific and ultrasensitive detection of SNPs. The incorporation 
of various biofunctionalised nanomaterials coupled with novel amplification strategies have 
permitted the detection of extremely low concentrations of SNPs, down to the aM - zM 
range. Such levels of sensitivity have already compared very favorably with many PCR based 
methods. In general, the amplification strategies may be classified as one of the following 
categories: 
(i) Nanoparticle–target assisted PCR amplification. 
(ii) Nanoparticle-target assisted probe amplification. 
(iii) Target recycling coupled with probe and/or signal amplification.  
(iv) Tandem amplification schemes and signal catalytic cascades. 
(v) Nanomaterial enhanced signal amplification. 
In general, the sensitivity of a nanomaterial-based SNP assay can be greatly enhanced by 
combining target, probe and signal amplification schemes. Most of the recent target and 
probe amplification schemes have exploited the great catalytic power and specificity of 
enzymes to achieve ultra-sensitivity and specificity. Of particular interest here is the use of 
DNAzymes that can undergo the so-called enzymatic cascade reactions, where the activation 
of multiple enzymes by a target DNA can result in ultra-sensitivity, comparable many PCR 
based assays. Another widely used strategy is the use of restriction enzymes that specifically 
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recognise the restriction sites to degrade the reporter probe, allowing for target recycling. 
These autocatalytic strategies have resulted in unmatched sensitivities while still maintaining 
high specificity. However, a limitation here is that restriction enzymes can only recognize a 
specific sequence and therefore are not suitable for universal SNP detection. Several 
ingenious ways in the design of nanomaterials for signal amplification strategies have also 
been developed, including the use of multiple tagging and enrichment of nanoparticle probes 
with signal moieties to enable ultra-sensitivity. Some of these strategies also hold great 
promises for multiplexed detection, an important property for high diagnostic accuracy. 
Despite significant advances, several limitations still need to be resolved before they can 
be translated into clinical diagnostic assays. For example, although a number of assays have 
reported aM, even zM sensitivity, most of which were still at the proof-of-concept stage and 
were carried out under clean buffers. They have not yet been tested in clinically related 
media, such as blood, serum, saliva and urine. Furthermore, most assays have reported a 
rather limited SNP discrimination ratio (< 10 fold), making them potentially unsuitable for 
detection of low abundant disease related SNPs in the background of wild-type gene/genomic 
DNA because of the strong interference from the background DNAs. Moreover, the lack of 
the multiplexing capability could pose a significant limiting factor for the real clinical 
potential. The stability of the biofunctionalised nanomaterials is another important issue for 
such nano-enabled SNP biosensors. In this regard, the fundamental understanding of the 
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biomolecule-nanomaterial interactions is imperative to alleviate problems of high background 
signals due to non-specific adsorptions in serum and/or other complex clinical samples. 
The use of biofunctionalised nanomaterials together with novel amplification strategies 
has transcended barriers to the attainment of extremely low detection limits of disease-related 
SNPs. This ultimately ushers the way for more practical concerns such as the realistic 
applications of the technology in clinical settings. Even more challenging is the development 
of a robust, portable, point-of-care diagnostic system that can specifically detect the ultralow 
level of disease-related SNPs rapidly and conveniently on the site of the patient and in places 
such as the doctor’s office, school clinic and in patients’ residence [89].  
These also calls for improving the assays’ amenability towards automation and 
miniaturization because most current assays still require the use of expensive and complex 
instrumentation and complex procedures, limiting their potential in rapid diagnosis. Electro- 
chemical signal transduction can provide an option for the miniaturization and automation but 
these methods are prone to false positives [26]. The recent advances in microfluidics [90-91] 
may be able to address sample throughput and automation challenges in SNP assays. If all of 
these challenges were met, the automation of these ultrasensitive assays may lead to the 
integration of sample processing, quantification and signal measurement in an all-in-one 
device in real clinical setting. This would greatly facilitate the rapid, accurate disease 
diagnosis and prognosis. In view of this, these are still crucial challenges that need to be 
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addressed, and more efforts will be needed to improve the analytical sensing performance and 
portability of SNP assays. 
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Figures and Tables 
Table 1: Comparison of the sensing performance of some ultrasensitive nano-enabled DNA 
detection assays. 
First Author 
Ref. 
Nanomaterial 
Platform 
Amplification 
strategy 
 Transducer / 
Analytical Tool 
LOD 
     
PCR Based Methods 
Y. Zhao [66] Au NP + Ag NP PCR Circular Dichroism 17 zM 
F. Patolsky 
[84] 
Magnetic NP PCR Chemiluminescence 8.6 aM 
PCR-free Methods 
W. Shen [40] Au NP LCR Colorimetric 20 aM 
D. Kato [75] 
Au NP and 
Magnetic NP 
LCR Colorimetric 50 zM 
J. Ji [46] CdTe QD Target recycling + RCA Electrochemical 11 aM 
S. Bi [50] Magnetic NP RCA + DNAzyme  Colorimetric 71 aM 
Y.P. Zeng 
[78] 
QD Primer generation + RCA Fluorimetric 50. 9 aM 
J. W. Nam 
[80] 
Au NP + Magnetic 
NP 
Bio-bar-code + silver 
amplification  
Scanometric  0.5 aM 
J. Hu [82] CdS QD 
CdS QD loaded in SiO2 
particles 
H2S Generation + 
Atomic Fluorescence 
Microscopy 
0.8 aM 
C. Ding [83] Au NP + CuS NP CuS NP loaded Au NP Electrochemical 19 aM 
R. D’Agata 
[85] 
Au NP  Short DNA modified Au NP 
Surface Plasmon 
Resonance Imaging 
2.6 aM 
J. Zhou [86] QD QD entrapped in liposome 
Single Particle 
Counting 
1-2.5 aM  
 
PCR: polymerase chain reaction; LCR: ligation chain reaction; LOD: limit of detection. 
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Fig. 1. Chiroplasmonic core-shell DNA-bridged nanoparticle heterodimers. (A) 
Schematic illustration of the PCR based assembly of Au nanoparticle dimers. (B) 
Deposition of Au and Ag on the DNA-bridged Au nanoparticle dimers leading to single 
and multiple core-shell heterodimers. (C) CD and UV−vis spectra of Au coated 
heterodimers with DNA concentrations varying from 16 zM to 1.6 pM. (D) Calibration 
curve relating the intensity of CD bands of Au coated heterodimers and the concentration 
of DNA. Reprinted with permission from ref. 66, copyright © 2014, American Chemical 
Society. 
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Fig 2. Schematic principle of the rolling cycle amplification and SNP discrimination. (A) 
Hybridization of the perfect-match target DNA to circular padlock probe leads to covalent 
ligation, producing a target DNA hybridized circular probe where in the presence of phi29 
polymerase and dNTP’s, the target serves as primer to initiate the circular extension of long 
single-stranded DNA with repeat sequence complementary to the padlock probe. (B) The 
presence of a single base mismatch between the target DNA to the padlock probe leads to no 
ligation and hence no amplification. 
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Fig. 3. Schematic principle of the ligase chain reaction (LCR) based DNA amplification 
strategy. Each of the two DNA strands in the duplex target serves as a template to ligate its 
respective two short DNA strands, leading to doubling of the ligated product in each cycle 
and hence an exponential amplification of the target DNA. The amplified target sequences 
can then be detected by using their specific  and  tags. 
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Fig. 4. (A) Schematic illustration of the real-time Au NP mediated LCR assay. (B) 
UV−Vis spectra of the solution containing 100 fM target DNA and 10 nM CP-coated 
AuNPs during the LCR process. Inset: color of solution after addition of 0, 5, and 50 nM 
(left to right) target DNA to 10 nM CP-coated AuNPs. Reprinted with permission from 
ref. 40, copyright © 2012, American Chemical Society. 
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Fig. 5. (A) Schematic illustration of Enzyme Free Click Chemical Ligation on Au 
nanoparticles involves the hybridization of the target DNA with an azide-modified Au NP 
(N3-AuNP), dibenzocyclooctyne-modified probe (DNCO-probe). (B) A plot of the 
A525(bk)/A525(s) ratio at diﬀerent target DNA concentrations using 40 thermal cycles. 
Inset shows a photograph of the supernatants at diﬀerent target DNA concentrations. 
Reprinted permission from ref. 75, copyright © 2014, American Chemical Society. 
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Fig. 6. (A) Schematic illustration of the TEHP ampliﬁcation strategy for DNA detection, (B) 
Stripping voltammetric curves of cadmium ions corresponding to (left to right) 10
−18
, 10
−17
 , 
10
−16
 , 10
−15 
, 10
−14
, 10
−13
, 10
−12
, 10
−11
, and 10
−10
 M of target DNA. (C) The corresponding 
analytical quantitative dynamic range. Reprinted permission from ref. 46, copyright © 2012, 
American Chemical Society. 
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Fig. 7 (A) Schematic representation of interlocked DNA scaffold mediated RCA reaction and 
DNAzyme amplification assay for the detection of G12C mutation in the KRAS gene. (B) 
Chemiluminescence signals for the HRP-mimicking DNAzyme-catalyzed luminol-H2O2 
system corresponding to different concentrations of single-base mutant target DNA: (a) 0; (b) 
0.1; (c) 0.2; (d) 0.4; (e) 0.6; (f) 0.8; (g) 1.0; (h) 2.0; (i) 4.0; (j) 6.0; (k) 8.0; (l) 10.0 fM. (C) 
The corresponding calibration curve of peak height versus the concentration of target DNA. 
Reprinted with permission from ref. 50, copyright © 2010, American Chemical Society. 
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Fig 8. Schematic illustration of the DNA-Bio-bar-code based ultrasensitive assay for DNA 
detection. (A) The preparation of the DNA modified Au NP and magnetic microparticle 
probes. (B) Schematics of the nanoparticle-based PCR-free DNA amplification and detection 
scheme. Reprinted with permission from ref. 80, copyright © 2004, American Chemical 
Society. 
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Fig. 9. Schematic illustration of the nanoparticle-enhanced SPRI strategy used to detect the 
normal βN/βN, heterozygous β°39/β°N, and homozygous β°39/β°39 genomic DNAs. The 
PNA-N and PNA-M recognize specifically the normal β-globin and the mutated β°39-globin 
genomic sequences, respectively. Reprinted with permission from ref. 85, copyright © 2011, 
American Chemical Society. 
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Fig. 10. (A) Schematic illustration for Liposome−QD complexes (L@QD complex) based 
ultrasensitive detection of attomolar DNA using single-particle detection techniques. The 
assay involves the sandwich type hybridization of the target DNA to L@QD complex-tagged 
reporter probes and capture probe modified - magnetic bead. Liposome disruption leads to the 
release of QD’s for single particle detection. (B) A plot of burst counts from the released QDs 
as a function of the concentrations of HIV-1 (green) and HIV-2 (red). There was no change in 
the burst counts in the control groups with non-complementary DNA (black and blue), and 
(C) Simultaneous detection of HIV-1 (green) and HIV-2 (red). The error bars corresponds to 
standard deviation of three replicates. Reprinted with permission from ref. 86, copyright © 
2013, American Chemical Society. 
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Fig. 11. (A) Schematic illustration of the proposed signal-generation mechanism by means of 
enzyme-guided crystal growth for the plasmonic ELISA assay. (B) Immunoassay for the 
ultrasensitive detection of PSA with GOx-labelled antibodies and of PSA (red) and BSA 
(green) spiked into whole serum. Reprinted with permission from ref. 87, copyright © 2012, 
Nature Publishing group. 
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